Стоит ли избегать imidazolidinone при беременности? | VeriMom
Animal reproduction data (multi‑generation / reproductive studies) report effects (reports / summaries cite reduced litter weights and reproductive NOAELs), and multiple safety data sheets / C&L inventory notifications list Repr.2 / H361 for 2‑imidazolidinone; however there is no harmonised CLH (no ECHA Annex VI H360) nor a formal CIR/SCCS opinion specific to CAS 120‑93‑4. Taken together this supports ‘suspected’ (h=2) but not confirmed teratogen status. (sources: ECHA substance pages / C&L notifications; literature summary of reproductive studies).
ECHA regulatory hazard statements
- •H361
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Безопасен ли imidazolidinone при беременности?
- Animal reproduction data (multi‑generation / reproductive studies) report effects (reports / summaries cite reduced litter weights and reproductive NOAELs), and multiple safety data sheets / C&L inventory notifications list Repr.2 / H361 for 2‑imidazolidinone; however there is no harmonised CLH (no ECHA Annex VI H360) nor a formal CIR/SCCS opinion specific to CAS 120‑93‑4. Taken together this supports ‘suspected’ (h=2) but not confirmed teratogen status. (sources: ECHA substance pages / C&L notifications; literature summary of reproductive studies).
- Безопасен ли imidazolidinone при грудном вскармливании?
- Same basis as pregnancy: animal reproduction findings and multiple supplier/SDS / C&L inventory notifications raising Repr.2 (H361) support a cautious classification of ‘suspected’ reproductive hazard. Direct data on lactational transfer or human breastfeeding outcomes were not located. Exposure via cosmetics expected to be low. (sources: supplier SDS / C&L notifications; literature summaries).
- Безопасен ли imidazolidinone для кожи малыша?
- Hazard (h=2) carried over from animal reproductive effects and H361 notifications. No infant‑specific studies were found. Dermal exposure assessment/data (dermal absorption rates in adults or infants) were not located — cosmetic exposure is likely low so exposure score remains 0; infant dermal absorption was not demonstrably quantified in available sources. (sources: SDS / C&L inventory; literature summaries).
- Как VeriMom оценивает imidazolidinone?
- VeriMom оценивает imidazolidinone в 39/100 (высокий риск) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы imidazolidinone при беременности?
- См. наш список безопасных альтернатив imidazolidinone с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.